Middle Peak Medical is a Munich-based, development-stage medical device company focused on commercializing a novel therapy for mitral valve disease. The company raised an additional $3M in a second closing of its over-subscribed Series A, bringing the Series A to approximately $11M in total. Backers in the second close included BioMedInvest II LP, Edwards LifeSciences, Wellington Partners and Seventure Partners. Middle Peak intends to use the funds to further develop its mitral valve treatment technology. Its platform targets both minimally invasive cardiac surgery and catheter-based percutaneous intervention. The company is led by CEO and co-founder Michael D. Lesh, MD, and maintains R&D operations in Palo Alto with clinical and regulatory operations in Germany. Middle Peak Medical is a development-stage medical device company based in Palo Alto, California, commercializing a novel technology for treating mitral valve disease. Its technology is intended for use in both minimally invasive cardiac surgery and catheter-based percutaneous intervention. Led by Michael D. Lesh, MD (CEO and co-founder), the company currently maintains operating entities in Germany and the United States, with its R&D center remaining in Palo Alto. On June 27, 2013, Middle Peak raised $8.5m in a Series A financing to further develop its mitral valve treatment technology. The round was co-led by Wellington Partners and Seventure Partners, with participation from High-Tech Gründerfonds. Following the financing, the company is establishing clinical and regulatory operations in Europe.

Total raised

$12M

Funding rounds

2

Latest round

Series A

Latest activity

Oct 2013